GlaxoSmithKline plc GLAXF Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board

Sep 13, 2013 at 8:41 PM

GlaxoSmithKline plc GLAXF Company Overview

Stock Message Board http://investorshangout.com/search?q=GLAXF&am...mp;yt1=Go!

GlaxoSmithKline plc GLAXF Current Price and Quotes
Last Price 25.461
Previous Close 25.74 Open 25.461
Daily Range 25.461 - 25.461 52wk Range 27.11 - 20.67
Volume 110 Dividend N/A
Average Vol (3m) 3,878 Yield N/A
GlaxoSmithKline plc GLAXF
Company Information

980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom

Website: http://www.gsk.com
Phone: +44 (0)20-8047-5000

GlaxoSmithKline plc GLAXF
GlaxoSmithKline plc GLAXF
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2012 20-F
CIK 0001131399
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Jean-Pierre Garnier CEO
John Coombe CFO
Simon Bicknell Secretary
Company Directors

Not Available
Company Notes

Formerly=Glaxo Wellcome plc until 12-00. Glaxo Wellcome plc merged with SmithKline Beecham plc. prior to name change. Basis: 1.138 GlaxoSmithKline plc ADRs for each SmithKline Beecham plc ADR held
Formerly=Glaxo, PLC until 5-95
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

GlaxoSmithKline plc GLAXF
GLAXF Security Details Other Company Securities

Share Structure

Market Value1 $133,661,402,868 a/o Sep 12, 2013
Shares Outstanding 5,192,670,000 a/o Jun 30, 2010
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

GSK - LSE - London Stock Exchange - Qualified
Short Selling Data

Short Interest 802,105 (-0.13%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

GlaxoSmithKline plc GLAXF Recent News

Sept 13, 2013 New Products, Philanthropic Initiative, Approved Acquisitions, and Pipeline Developments Boost Growth - Research Report on Mylan, UnitedHealth, GSK, Actavis, and Mallinckrodt
Sept 13, 2013 ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
Sept 12, 2013 GSK research estimates significantly higher rates of pertussis among older adults than now reported
Sept 11, 2013 Flamel Technologies Announces Acceptance of FDA Review for Second NDA
Sept 11, 2013 Prospect of generic asthma drug Advair hits Glaxo
Sept 10, 2013 FDA Advisory Committee Recommends Approval in US of Umeclidinium/Vilanterol for the Treatment of COPD
Sept 10, 2013 Glaxo to sell two soft drink brands
Sept 10, 2013 GSK changes focus afer ditching famous brands
Sept 10, 2013 COPD Biomarker Qualification Consortium Making Strides with Plasma Fibrinogen as New Biomarker
Sept 10, 2013 Deal Negotiation is Top Priority at BioPharm America(TM) 2013 in Boston

1
2
3
4
5
6
7
8
next >
last >>

GlaxoSmithKline plc GLAXF Financials
Period Ending Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue 42,563,000 44,452,000 45,810,000 35,259,261
Cost of Revenue 11,395,000 11,886,000 11,918,000 9,288,279
Gross Profit 31,168,000 32,566,000 33,893,000 25,970,982
Operating Expenses

Research and Development 6,230,000 6,978,000 6,631,000 5,329,720
Sales, General and Admin. 12,805,000 19,665,000 13,657,000 11,085,122
Non-Recurring Items - - - (783,314)
Other - - - -
Operating Income 12,133,000 5,923,000 13,605,000 10,339,454
Income From Continuing Operations

Add'l Income/Expense Items 1,049,000 195,000 (965,000) 453,193
Earnings Before Interest and Tax 13,206,000 6,244,000 12,743,000 10,862,146
Interest Expense 1,242,000 1,301,000 - 1,220,580
Earnings Before Tax 11,964,000 4,943,000 12,743,000 9,641,566
Income Tax 3,481,000 2,042,000 3,588,000 2,819,061
Minority Interest 306,000 343,000 223,000 -
Equity Earnings Unconsolidated Subsidiary 23,000 127,000 103,000 69,499
Net Income Cont. Operations 8,200,000 2,685,000 9,035,000 6,822,505
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 8,200,000 2,685,000 8,932,000 6,822,505
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 8,176,000 2,558,000 8,932,000 6,822,505

GLAXF GlaxoSmithKline plc Research DD Guide

GLAXF GlaxoSmithKline plc Stock Message Board http://investorshangout.com/search?q=GLAXF&am...mp;yt0=Go!
GLAXF GlaxoSmithKline plc Stock Quote http://www.otcmarkets.com/stock/GLAXF/quote
GLAXF GlaxoSmithKline plc Stock Chart http://www.otcmarkets.com/stock/GLAXF/chart
GLAXF GlaxoSmithKline plc Company Info http://www.otcmarkets.com/stock/GLAXF/company-info
GLAXF GlaxoSmithKline plc Recent News http://www.otcmarkets.com/stock/GLAXF/news
GLAXF GlaxoSmithKline plc Financials http://www.otcmarkets.com/stock/GLAXF/financials
GLAXF GlaxoSmithKline plc Filings and Disclosure http://www.otcmarkets.com/stock/GLAXF/filings
GLAXF GlaxoSmithKline plc Short Sales http://www.otcmarkets.com/stock/GLAXF/short-sales
GLAXF GlaxoSmithKline plc Insider Disclosure http://www.otcmarkets.com/stock/GLAXF/insider-transactions
GLAXF GlaxoSmithKline plc Research Reports http://www.otcmarkets.com/stock/GLAXF/research
GLAXF GlaxoSmithKline plc Summary http://finance.yahoo.com/q?s=GLAXF
GLAXF GlaxoSmithKline plc Historical Prices http://finance.yahoo.com/q/hp?s=GLAXF+Historical+Prices
GLAXF GlaxoSmithKline plc Interactive Chart http://finance.yahoo.com/echarts?s=GLAXF
GLAXF GlaxoSmithKline plc Basic Chart http://finance.yahoo.com/q/bc?s=GLAXF+Basic+Chart
GLAXF GlaxoSmithKline plc Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GLAXF+Basic+Tech.+Analysis
GLAXF GlaxoSmithKline plc Headlines http://finance.yahoo.com/q/h?s=GLAXF+Headlines
GLAXF GlaxoSmithKline plc Press Releases http://finance.yahoo.com/q/p?s=GLAXF+Press+Releases
GLAXF GlaxoSmithKline plc Company Profile http://finance.yahoo.com/q/pr?s=GLAXF+Profile
GLAXF GlaxoSmithKline plc Key Statistics http://finance.yahoo.com/q/ks?s=GLAXF+Key+Statistics
GLAXF GlaxoSmithKline plc Industry http://finance.yahoo.com/q/in?s=GLAXF+Industry
GLAXF GlaxoSmithKline plc Major Holders http://finance.yahoo.com/q/mh?s=GLAXF+Major+Holders
GLAXF GlaxoSmithKline plc Insider Transactions http://finance.yahoo.com/q/it?s=GLAXF+Insider+Transactions
GLAXF GlaxoSmithKline plc Insider Roster http://finance.yahoo.com/q/ir?s=GLAXF+Insider+Roster
GLAXF GlaxoSmithKline plc Income Statement http://finance.yahoo.com/q/is?s=GLAXF
GLAXF GlaxoSmithKline plc Balance Sheet http://finance.yahoo.com/q/bs?s=GLAXF
GLAXF GlaxoSmithKline plc Cash Flow http://finance.yahoo.com/q/cf?s=GLAXF+Cash+Flow&annual
GLAXF GlaxoSmithKline plc Nasdaq http://www.nasdaq.com/symbol/GLAXF
GLAXF GlaxoSmithKline plc Market Watch http://www.marketwatch.com/investing/stock/GLAXF
GLAXF GlaxoSmithKline plc Bloomberg http://www.bloomberg.com/quote/GLAXF:US
GLAXF GlaxoSmithKline plc Morningstar http://quotes.morningstar.com/stock/s?t=GLAXF
GLAXF GlaxoSmithKline plc Bussinessweek http://investing.businessweek.com/research/st...cker=GLAXF
GLAXF GlaxoSmithKline plc Barchart http://www.barchart.com/quotes/stocks/GLAXF
GLAXF GlaxoSmithKline plc OTC Short Report http://otcshortreport.com/index.php?index=GLAXF
GLAXF GlaxoSmithKline plc Investopedia http://www.investopedia.com/markets/stocks/GLAXF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

University of Phoenix Leads Credentialing Dialogue at Summit

Credentials in the Spotlight at PESC Summit When you're talking credentials and data standards at the PESC Summit, you've got a gathering of big brains aiming to steer the wild ride of higher education into the future. This October, University of Phoenix leaders stepped up to the plate in Scottsdale, Arizona, delivering a frank talk about the role of credentials in...

Co-op Giants Earn $309B: Key Players Spotlighted

Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...

ADT Shareholders Face Legal Scrutiny in M&A Deal

ADT Shareholders on High Alert Listen up, folks. Anyone holding shares in ADT Inc. (NYSE: ADT) needs to sharpen their pencils and start crunching numbers. This isn't the time to sit back and coast. A M&A Class Action investigation is brewing, and it's centered on ADT's sale to Thrive Holdings. The $10.00 per share buyout offer might look neat and tidy, but there's more to...

Class Action Looms Over Tenax Therapeutics Investors

Shareholders in the Crosshairs Every once in a while, the market serves up a cold dish of reality, and folks owning Tenax Therapeutics (NASDAQ:TENX) are facing just that. A class action is casting a long shadow, targeting those who bought in between November 13, 2023, and August 7, 2026. It's the kind of headache that no investor wakes up hoping for. The Allegations: When...

PRTH Shareholder Concerns Amid Merger Investigation

Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....

Investigations Target PAG, BRBS, PSNL for Fair Shareholder Deals

Unpacking the Shareholder's Dilemma in Major Transactions Alright, folks, let's dig into this mess with our favorite Wall Street magnifying glass. We've got Penske Automotive Group (NYSE: PAG), Blue Ridge Bankshares (NYSE: BRBS), and Personalis, Inc. (NASDAQ: PSNL) under the spotlight, each locking themselves into deals that might not exactly scream 'fair play' for the...

The Sift: Slickdeals’ Game-Changing Black Friday Tool

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Holiday Shoppers Eye Payment Options Amid Tight Budgets

Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....

Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...